Skip to main content
Premium Trial:

Request an Annual Quote

Alnylam, AlCana Researchers Detail Lipid-development Effort

Premium

Alnylam Pharmaceuticals researchers last month published details on the company’s efforts to improve lipid nanoparticles for RNAi drug delivery.

In Molecular Therapy, the scientists noted that the key challenge to improving the delivery vehicles “was to introduce biodegradable functionality in such a way as to promote rapid in vivo metabolism into more hydrophilic, water-soluble products, while maintaining the excellent potency of the most advanced lipids currently available.”

To do so, they and collaborators from AlCana Technologies designed a lipid structure so that the biocleavable groups were positioned within the hydrophobic lipid tails, according to the paper. Ester linkages were also selected due to their “simple structure, good chemical stability, and potential for rapid enzymatic cleavage in vivo,” they noted in the paper.

Overall, the lipid the team designed “incorporates biodegradability into design principles elucidated in prior structure-activity relationship studies, resulting in rapid elimination and excretion, substantial tolerability, and excellent potency” in rodents and non-human primates, they wrote. “To our knowledge, this is the first demonstration of a biodegradable lipid with an efficacy profile on par with that of the most advanced lipids currently available for siRNA delivery.”

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.